Clinical trial NCT05066308
Status: Completed, results awaitedPhase 2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Cannabidiol for Reduction of Brain Neuroinflammation
- Record number
- NCT05066308
- Status
- Completed, results awaited
- Type and phase
- Clinical trial, phase 2
- Participants
- 69 (actual)
- Condition (as registered)
- Back Pain, Depressive Symptoms
- Countries
- United States
- Topic in the guide
- Chronic Pain, Depression
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: January 4, 2022
- End of data collection for primary results: April 17, 2026
- Trial completion: May 1, 2026
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Completed, results awaited.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Chronic Pain: ongoing trials · Depression: ongoing trials · Thinking of taking part? Which specialist to see